tradingkey.logo
tradingkey.logo
Buscar

Mesa Laboratories Inc

MLAB
Añadir a la lista de seguimiento
105.540USD
+1.150+1.10%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
583.10MCap. mercado
160.59P/E TTM

Más Datos de Mesa Laboratories Inc Compañía

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Información de Mesa Laboratories Inc

Símbolo de cotizaciónMLAB
Nombre de la empresaMesa Laboratories Inc
Fecha de salida a bolsaFeb 29, 1984
Director ejecutivoOwens (Gary M)
Número de empleados730
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 29
Dirección12100 W 6th Ave
CiudadLAKEWOOD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80228
Teléfono13039878000
Sitio Webhttps://mesalabs.com
Símbolo de cotizaciónMLAB
Fecha de salida a bolsaFeb 29, 1984
Director ejecutivoOwens (Gary M)

Ejecutivos de Mesa Laboratories Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.85%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
46.44K
+10.21%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.85%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
46.44K
+10.21%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Mesa Laboratories Inc?

Los cinco principales accionistas de Mesa Laboratories Inc son: Mr. Gary M. Owens

¿Cuántas instituciones poseen acciones de Mesa Laboratories Inc (MLAB)?

A fecha de 2026Q1, 397 instituciones poseen acciones de Mesa Laboratories Inc, con un valor de mercado combinado de aproximadamente 5.55M, lo que representa el 100.49% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -254194.00.

¿Cuál es la mayor fuente de ganancias de Mesa Laboratories Inc?

El 2026Q1, el segmento empresarial Discrete Revenues- Consumables generó la ganancia más alta para Mesa Laboratories Inc, ascendiendo a 36.73M y representando el 56.40% de la ganancia total.